These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7000669)

  • 1. Cellular origins and targets of costimulator (IL2).
    Paetkau V; Shaw J; Mills G; Caplan B
    Immunol Rev; 1980; 51():157-75. PubMed ID: 7000669
    [No Abstract]   [Full Text] [Related]  

  • 2. T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.
    Wagner H; Hardt C; Heeg K; Pfizenmaier K; Solbach W; Bartlett R; Stockinger H; Röllinghoff M
    Immunol Rev; 1980; 51():215-55. PubMed ID: 7000672
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.
    Shaw J; Caplan B; Paetkau V; Pilarski LM; Delovitch TL; McKenzie IF
    J Immunol; 1980 May; 124(5):2231-9. PubMed ID: 6965968
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 dependent culture of cytolytic T cell lines.
    Gillis S; Watson J
    Immunol Rev; 1981; 54():81-109. PubMed ID: 7019041
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 2 in cell-mediated immune responses.
    Paetkau V; Shaw J; Caplan B; Mills GB; Lee KC
    J Supramol Struct; 1980; 13(2):271-80. PubMed ID: 6972471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lymphocyte growth factor made by a human lymphoid cell line.
    Sanderson R; Vesole D; Jakway J; Talmage D
    Immunol Rev; 1980; 51():177-91. PubMed ID: 7000670
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of mouse interleukins.
    Henriksen O; Alvarez VL; Barnes M; Bächtold H; Frey JR; Hansson E; Howie S; Lefkovits I; Roitsch CA; Söderberg A; Young P
    FEBS Lett; 1980 Nov; 121(1):157-60. PubMed ID: 6780374
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of costimulator on immune responses in vitro.
    Shaw J; Monticone V; Mills G; Paetkau V
    J Immunol; 1978 Jun; 120(6):1974-80. PubMed ID: 149174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the immune response T-cell interactions.
    Dutton RW; Swain SL
    CRC Crit Rev Immunol; 1982 Feb; 3(3):209-61. PubMed ID: 6176399
    [No Abstract]   [Full Text] [Related]  

  • 10. Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.
    Wang BS; Heacock EH; Zheng CX; Tilney NL; Mannick JA
    Transplantation; 1982 Apr; 33(4):454-6. PubMed ID: 6978560
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of T cell responses through competition for T cell growth factor (interleukin 2).
    Günther J; Haas W; Von Boehmer H
    Eur J Immunol; 1982 Mar; 12(3):247-9. PubMed ID: 6212257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of accessory cells in polyclonal T cell activation. I. Both induction of interleukin 2 production and of interleukin 2 responsiveness by concanavalin A are accessory cell dependent.
    Hünig T; Loos M; Schimpl A
    Eur J Immunol; 1983 Jan; 13(1):1-6. PubMed ID: 6601004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte-macrophage interactions in cellular antibacterial immunity.
    Hahn H; Kaufmann SH
    Immunobiology; 1982 Apr; 161(3-4):361-8. PubMed ID: 6807832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.
    Shaw J; Monticone V; Paetkau V
    J Immunol; 1978 Jun; 120(6):1967-73. PubMed ID: 307026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspecific "lymphocyte activating" factors produced by macrophages.
    Diamantstein T; Oppenheim JJ; Unanue ER; Wood DD; Handschumacher RE; Rosenstreich DL; Waksman BH
    Clin Immunol Immunopathol; 1979 Oct; 14(2):264-7. PubMed ID: 226303
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of hybridoma macrophages.
    Martin CA; Falkenberg F; Willmer U; Liu YN; Uchida T; Ju ST; Dorf ME
    Ann Inst Pasteur Immunol (1985); 1986; 137C(2):240-44. PubMed ID: 3089127
    [No Abstract]   [Full Text] [Related]  

  • 17. The in vivo effects of interleukin 2 (TCGF).
    Wagner H; Hardt C; Heeg K; Pfizenmaier K; Stötter H; Röllinghoff M
    Immunobiology; 1982 Mar; 161(1-2):139-56. PubMed ID: 6178678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells.
    Reddehase M; Suessmuth W; Moyers C; Falk W; Droege W
    J Immunol; 1982 Jan; 128(1):61-8. PubMed ID: 6172493
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of lymphocyte proliferation and differentiation by lymphokines.
    Schimpl A
    Curr Top Microbiol Immunol; 1982; 98():81-4. PubMed ID: 6979464
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure of antigen-specific suppressor factors: current views.
    Kontiainen SK; James RF; Culbert EJ; Feldmann M
    Surv Immunol Res; 1982; 1(1):17-23. PubMed ID: 6195709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.